Podcasts
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live-talk, session 20 – new drugs and therapies in the pipeline for acromegaly and Cushing’s
Today we present an excellent discussion with Dr. Alan Krasner, Chief Medical Officer for Crinetics Pharmaceuticals. Dr. Krasner speaks to PWN about two very important drugs currently under development.
Live-talk, session 19 – Adenomas and Pituitary Neuroendocrine Tumors
The ongoing debates and nomenclature change and reclassification are apparently over, and adenomas are now referred to as Pit-Net’s (pituitary neuroendocrine tumors). Is this good, bad, or indifferent?
Pseudo Cushing’s syndrome: a discussion and a case study
In today’s podcasts, Dr. Blevins talks about the genesis of pseudo Cushing’s syndrome and illustrates a fascinating case of pseudo Cushing’s syndrome due to alcohol ingestion.
Live-talk, session 18 – What is medical decision-making?
What does medical decision-making mean, and what is involved? What are pituitary specialists thinking about when faced with decisions on how to treat a patient? This live talk session aims at answering these tough questions. This podcast will shed some light on what a physician does when making medical decisions. Enjoy!
Lab result targets
In this podcast from our “musings series” comes an interesting discussion on lab result targets. This case comes from a hypothyroid patient who wanted to achieve a particular TSH lab result target. In the discussion, Dr. Blevins focuses on how the pituitary works, how lab tests work, and what makes aiming at and achieving a narrow target almost impossible.
Live-talk, session 17 – Pituitary surgery: before, during and after
Do you ever wonder what happens in the OR after you are wheeled in? We welcome once again our friend and contributor, Manish Aghi, M.D. Ph.D., Attending Neurosurgeon at the California Center for Pituitary Disorders, Professor of Neurological Surgery, and Principal Investigator at UCSF Brain Tumor Research Center. He spent an amazing hour with Dr. Blevins and me, walking us through his work with patients before surgery, his approaches post-surgery, recovery, potential issues, and the many other phases of pituitary surgery.
Live talk, session 16 – Awareness and knowledge
To continue our focus on pituitary awareness month, this session touches on various issues related to awareness and its importance as a critical factor in reducing the time to diagnosis.
Live talk, session 15 – A chat with preeminent pituitary neurosurgeon Dr. Sandeep Kunwar
If you didn’t have a chance to hear it live, here’s a podcast from the live talk session from last Thursday with special guest and PWN friend and contributor Pituitary neurosurgeon Dr. Sandeep Kunwar. He joined Dr. Lewis Blevins for a great discussion of the latest in pituitary surgery and disease management.
Live talk, session 14 – Hair and Hormones
An informative discussion on the effects of hormones on hair loss, a common occurrence for people dealing with pituitary conditions. In this LIve-talk session, Dr. Blevins discusses the facts and the myths.
Live talk, session 13 – On this live talk session: a path to better systems
On our Live-talk program today, a fascinating, nothing left on the table, discussion about a variety of topics that affect pituitary patients; from access to medication and therapies to problems with social media and misinformation to the complexities of diagnosis and refuting diagnosis to the role of the doctor and the patient to solve many of these challenges.
Diabetes Insipidus: a common condition for Histiocytosis and Pituitary conditions
Today’s podcast focuses on an opportunity to learn about a group of rare diseases that share a common condition with pituitary disease. Histiocytosis or histiocytic disorders are a group of rare diseases that occur when there is an overproduction of white blood cells known as histiocytes that can lead to organ damage and tumor formation. DI impacts almost 50% of Histiocytosis patients and 35% of pituitary patients.
Live talk, session 12 – August 4, 2022: Residual and recurring Cushing’s
It’s always fascinating to listen to two of the recognized experts and leading clinicians in Cushing’s disease discuss their experiences with the disease and patients. In this Live Talk session, Pituitary World New’s innovative program for education and awareness, Dr. Kevin Yuen and Dr. Lewis Blevins bring an intimate, revealing look at their approaches to Cushing’s disease and syndrome.